DAN, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.116
EU - Europa 856
AS - Asia 307
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
SA - Sud America 1
Totale 2.361
Nazione #
US - Stati Uniti d'America 1.109
IT - Italia 260
GB - Regno Unito 171
SE - Svezia 143
CN - Cina 116
SG - Singapore 103
DE - Germania 80
IE - Irlanda 41
IN - India 39
TG - Togo 31
RU - Federazione Russa 28
FI - Finlandia 21
FR - Francia 19
BG - Bulgaria 17
EU - Europa 15
CH - Svizzera 14
JO - Giordania 14
ZA - Sudafrica 14
EE - Estonia 13
AT - Austria 11
UA - Ucraina 11
CI - Costa d'Avorio 9
NG - Nigeria 8
CA - Canada 7
NL - Olanda 7
ID - Indonesia 6
ES - Italia 5
PK - Pakistan 5
IR - Iran 4
JP - Giappone 4
TR - Turchia 4
MY - Malesia 3
AU - Australia 2
BE - Belgio 2
DK - Danimarca 2
HU - Ungheria 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PL - Polonia 2
PT - Portogallo 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CZ - Repubblica Ceca 1
HR - Croazia 1
KW - Kuwait 1
LI - Liechtenstein 1
LT - Lituania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 2.361
Città #
Southend 156
Chandler 153
Fairfield 145
Bologna 97
Singapore 92
Ashburn 84
Seattle 61
Houston 54
Woodbridge 50
Wilmington 43
Dublin 41
Cambridge 39
New York 37
Princeton 36
Lomé 31
Santa Clara 31
Ann Arbor 28
Boardman 26
Helsinki 21
Sofia 17
Nanjing 16
Amman 14
Beijing 14
Florence 14
Turin 14
Westminster 14
Bern 13
Bremen 13
Padova 12
Redmond 11
Los Angeles 10
Abidjan 9
Abeokuta 8
Milan 8
Berlin 7
Guangzhou 7
Jinan 7
San Diego 7
Vienna 7
Jakarta 6
Redwood City 6
Saint Petersburg 6
Toronto 6
Vicenza 6
Zhengzhou 6
Boydton 5
Medford 5
Rome 5
Tianjin 5
Washington 5
York 5
Amsterdam 4
Hyderabad 4
Istanbul 4
Nanchang 4
Osimo 4
Phoenix 4
San Francisco 4
Shenyang 4
Tokyo 4
Andover 3
Assisi 3
Changsha 3
Jiaxing 3
Kuala Lumpur 3
London 3
Olalla 3
Reggio Emilia 3
Springfield 3
Wuhan 3
Brussels 2
Castenaso 2
Cesenatico 2
Copenhagen 2
Correggio 2
El Cerrito 2
Forlì 2
Formigine 2
Genoa 2
Gradara 2
Granarolo dell'Emilia e Viadagola 2
Hangzhou 2
Hebei 2
Imola 2
Jacksonville 2
Kiel 2
Kuban 2
Leawood 2
Lisbon 2
Moscow 2
Mülheim 2
Napoli 2
New Bedfont 2
Norwalk 2
Palma 2
Ravenna 2
Romainville 2
San Lazzaro di Savena 2
Sukkur 2
Taizhou 2
Totale 1.639
Nome #
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 152
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 148
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 133
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 126
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 125
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. 123
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice 123
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 122
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 120
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 116
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 116
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 115
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 102
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 92
null 86
CD133+ stem cells for the treatment of end-stage liver disease 74
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 73
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy 68
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 66
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 61
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 45
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 36
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 32
Epigenetic age acceleration in hematopoietic stem cell transplantation 10
Totale 2.431
Categoria #
all - tutte 7.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020300 0 0 0 0 0 42 60 59 70 28 25 16
2020/2021158 47 9 8 1 8 11 6 6 24 16 5 17
2021/2022381 13 30 8 30 35 14 9 26 18 50 85 63
2022/2023642 66 96 34 74 44 49 25 39 98 9 64 44
2023/2024258 23 34 16 33 18 80 5 9 3 18 13 6
2024/2025380 44 92 71 61 70 42 0 0 0 0 0 0
Totale 2.431